Meitav Investment House Ltd. Sells 159,840 Shares of SPDR S&P Biotech ETF $XBI

Meitav Investment House Ltd. trimmed its stake in SPDR S&P Biotech ETF (NYSEARCA:XBI) by 16.5% during the 1st quarter, according to its most recent disclosure with the Securities and Exchange Commission. The institutional investor owned 809,579 shares of the exchange traded fund’s stock after selling 159,840 shares during the quarter. SPDR S&P Biotech ETF accounts for 1.1% of Meitav Investment House Ltd.’s portfolio, making the stock its 23rd biggest holding. Meitav Investment House Ltd. owned about 1.27% of SPDR S&P Biotech ETF worth $103,407,000 as of its most recent filing with the Securities and Exchange Commission.

A number of other institutional investors have also recently modified their holdings of XBI. Avoro Capital Advisors LLC bought a new position in SPDR S&P Biotech ETF in the 4th quarter worth about $256,053,000. Wells Fargo & Company MN increased its stake in SPDR S&P Biotech ETF by 75.7% during the 4th quarter. Wells Fargo & Company MN now owns 3,566,265 shares of the exchange traded fund’s stock valued at $434,835,000 after purchasing an additional 1,536,122 shares in the last quarter. OMERS ADMINISTRATION Corp raised its holdings in SPDR S&P Biotech ETF by 42,425.2% in the fourth quarter. OMERS ADMINISTRATION Corp now owns 1,190,707 shares of the exchange traded fund’s stock worth $145,147,000 after buying an additional 1,187,907 shares during the last quarter. Morgan Stanley raised its holdings in SPDR S&P Biotech ETF by 8.3% in the fourth quarter. Morgan Stanley now owns 11,491,683 shares of the exchange traded fund’s stock worth $1,401,181,000 after buying an additional 882,718 shares during the last quarter. Finally, Assetmark Inc. raised its holdings in SPDR S&P Biotech ETF by 1,042,265.6% in the fourth quarter. Assetmark Inc. now owns 635,843 shares of the exchange traded fund’s stock worth $77,528,000 after buying an additional 635,782 shares during the last quarter.

SPDR S&P Biotech ETF Stock Up 1.2%

Shares of NYSEARCA XBI traded up $1.87 during midday trading on Tuesday, hitting $162.68. The stock had a trading volume of 3,933,106 shares, compared to its average volume of 9,333,116. The business’s 50 day moving average is $137.94 and its 200-day moving average is $130.29. SPDR S&P Biotech ETF has a 52 week low of $83.45 and a 52 week high of $162.75. The company has a market cap of $11.00 billion, a P/E ratio of 11.47 and a beta of 0.82.

SPDR S&P Biotech ETF Profile

SPDR S&P Biotech ETF (the Fund) seeks to closely match the returns and characteristics of the S&P Biotechnology Select Industry Index. The S&P Biotechnology Select Industry Index represents the biotechnology sub-industry portion of the S&P Total Markets Index. The S&P TMI tracks all the United States common stocks listed on the New York Stock Exchange, American Stock Exchange, National Association of Securities Dealers Automated Quotation (NASDAQ) National Market and NASDAQ Small Cap exchanges. The Biotech Index is a modified equal weight index.